Jolanta Kosek

1.3k citations
15 papers · 830 indexed · h-index 9
Topics
Protein Degradation and Inhibitors (7 papers)Multiple Myeloma Research and Treatments (6 papers)Chronic Lymphocytic Leukemia Research (4 papers)

In The Last Decade

Jolanta Kosek

15 papers receiving 808 citations

Peers

Jolanta Kosek
Comparison fields: 5 of 92
  • Molecular Biology 528
  • Genetics 196
  • Hematology 178
  • Oncology 160
  • Immunology 140
Replace Seppo Pakkala with:
Seppo Pakkala Finland
Ana-Teresa Maia United Kingdom
Ricardo López‐Pérez Spain
Clémence Carron France
Ahmed Aribi United States
Hye‐Sook Kwon United States
Jennifer J. Tsai United States
Marina Lanciotti Italy
Kathleen W. Rao United States
Monica Taborelli Italy
Jolanta Kosek relative to Seppo Pakkala Finland Seppo Pakkala's profile →
Citations per field
00.5×11.8×
Seppo Pakkala · 1×
Citations per year

Countries citing papers authored by Jolanta Kosek

Since Specialization
Citations

This map shows the geographic impact of Jolanta Kosek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolanta Kosek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolanta Kosek more than expected).

Fields of papers citing papers by Jolanta Kosek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolanta Kosek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolanta Kosek. The network helps show where Jolanta Kosek may publish in the future.

Co-authorship network of co-authors of Jolanta Kosek

This figure shows the co-authorship network connecting the top 25 collaborators of Jolanta Kosek. A scholar is included among the top collaborators of Jolanta Kosek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolanta Kosek. Jolanta Kosek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 45
2 57
3 39
4 1
5 92
6 2
7 98
8 5
9 123
10 8
11 2
12 2
13 328
14
Modulation of apoptosis in human myeloid leukemic cells by GM-CSF.
24
15 4

About Jolanta Kosek

Jolanta Kosek is a scholar working on Hematology, Genetics and Developmental Neuroscience, having authored 15 papers that have together received 830 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Hematology (178 citations), Genetics (117 citations) and Molecular Biology (528 citations). Jolanta Kosek has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Peter Schäfer, Rajesh Chopra, Vundavalli V. Murty, Nicole Schupf, Benjamin Tycko, Éric Vilain, Mitzi Morris, Eldad A. Hod, Alexandra Spadola and Rui Yuan. Their work appears in journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026